Transplantation, AutologousPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationMultiple MyelomaStem Cell TransplantationMelphalanTransplantation ConditioningHematopoietic Stem Cell MobilizationTransplantation, HomologousCombined Modality TherapyAntineoplastic Combined Chemotherapy ProtocolsHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34CyclophosphamideTreatment OutcomeMyeloablative AgonistsRemission InductionBlood Component RemovalGraft vs Host DiseaseLymphoma, Non-HodgkinBusulfanBone Marrow TransplantationEtoposideSalvage TherapyRecurrenceThiotepaGraft SurvivalHematopoietic Stem CellsStem CellsDisease-Free SurvivalAntineoplastic Agents, AlkylatingCarmustineVincristineHodgkin DiseaseCytarabineSurvival RateAmyloidosisBoronic AcidsRetrospective StudiesPyrazinesIfosfamideDexamethasoneSurvival AnalysisThalidomideWhole-Body IrradiationDoxorubicinPrednisoneCord Blood Stem Cell TransplantationTransplantation ChimeraBone Marrow PurgingCytophagocytosisTissue DonorsHematopoiesisTime FactorsFollow-Up StudiesAntineoplastic AgentsNeoplasmsPrognosisLeukemia, Myeloid, AcuteHistocompatibilityLymphomaHistocompatibility TestingImmunosuppressive AgentsBone MarrowInfectionCarboplatinLiver TransplantationPlatelet CountVidarabineLymphoma, T-CellLeukemiaProspective StudiesTransplantation, IsogeneicFatal OutcomePOEMS SyndromeAutograftsMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationFeasibility StudiesGraft vs Leukemia EffectMaintenance ChemotherapyRecombinant ProteinsImmunophenotypingPlasma CellsCytomegalovirus InfectionsBlood Cell CountNeoplasm, ResidualCell TransplantationLymphoma, Mantle-CellInduction ChemotherapyFlow CytometryBlood CellsBlood Transfusion, AutologousAntibodies, Monoclonal, Murine-DerivedBone Marrow CellsKidney TransplantationT-LymphocytesEmbryonic Stem Cells